UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036103
Receipt number R000041125
Scientific Title A Study of Peripheral Oxygen Saturation Measured by A New Pulse Oximeter in Hypoxic Environment in a healthy person
Date of disclosure of the study information 2019/03/11
Last modified on 2022/09/08 12:52:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study of Peripheral Oxygen Saturation Measured by A New Pulse Oximeter in Hypoxic Environment in a healthy person

Acronym

A Study of Peripheral Oxygen Saturation Measured by A New Pulse Oximeter in Hypoxic Environment in a healthy person

Scientific Title

A Study of Peripheral Oxygen Saturation Measured by A New Pulse Oximeter in Hypoxic Environment in a healthy person

Scientific Title:Acronym

A Study of Peripheral Oxygen Saturation Measured by A New Pulse Oximeter in Hypoxic Environment in a healthy person

Region

Japan


Condition

Condition

healthy volunteers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate peripheral oxygen saturation measured by A new pulse oximeter in hypoxic environment

Basic objectives2

Others

Basic objectives -Others

Adverse events

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To evaluate peripheral oxygen saturation measured by A new pulse oximeter in hypoxic environment

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Hypoxic Environment

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >

Gender

Male and Female

Key inclusion criteria

1. person who is healthy
2. BMI: >=18.5, <30.0
2. person who provides consent and signs up the consent form

Key exclusion criteria

1. baseline SpO2 < 94% at screening
2. person who has some acute or chronic disease that requires medical treatment
3. person who has abnormalities which interfere with measurements on fingers
4. person who has any abnormal findings to need treatment

Target sample size

3


Research contact person

Name of lead principal investigator

1st name Naoyuki
Middle name
Last name Otani

Organization

Oita University Faculty of Medicine

Division name

Dept of Clinical Pharmacology & Therapeutics

Zip code

8795593

Address

1-1 Idaigaoka, Hasama, Yufu-city, Oita, JAPAN

TEL

097-586-5952

Email

naoyuki@oita-u.ac.jp


Public contact

Name of contact person

1st name Naoyuki
Middle name
Last name Otani

Organization

Oita University Faculty of Medicine

Division name

Dept of Clinical Pharmacology & Therapeutics

Zip code

879-5593

Address

1-1 Idaigaoka, Hasama, Yufu-city, Oita, JAPAN

TEL

097-586-5952

Homepage URL


Email

naoyuki@oita-u.ac.jp


Sponsor or person

Institute

Dept of Clinical Pharmacology & Therapeutics, Oita University Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

Oita medical robot and equipment Industry Council and HOKS Inc.

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

HOKS Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Oita university

Address

1-1 Idaigaoka, Hasama, Yufu-city, Oita, JAPAN

Tel

097-586-6163

Email

gcrcjimu@oita-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 03 Month 11 Day


Related information

URL releasing protocol

none

Publication of results

Unpublished


Result

URL related to results and publications

none

Number of participants that the trial has enrolled

6

Results

Five healthy volunteers (four males and one female) were receiving inhaled medical oxygen-nitrogen gas to create a hypoxic environment.

Results date posted

2022 Year 09 Month 08 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Median age of patients enrolled was 35 years (range 30-36)

Participant flow

Six healthy volunteers were screened and one was excluded because his BMI was outside the threshold.

Adverse events

One patient had severe pain from the root of the nose to the bridge of the nose when wearing the mask, and the study was stopped before the hypoxic environment was reached.

Outcome measures

SpO2 was measured using a pulse oximeter.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 02 Month 12 Day

Date of IRB

2019 Year 02 Month 12 Day

Anticipated trial start date

2019 Year 03 Month 18 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 03 Month 06 Day

Last modified on

2022 Year 09 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041125


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name